FGFR1 Gene Trigonocephaly Type 1 NGS Genetic DNA Test
Introduction
The FGFR1 Gene Trigonocephaly Type 1 NGS Genetic DNA Test is a specialized genetic test that focuses on identifying mutations in the FGFR1 gene, which are associated with trigonocephaly and other dysmorphological conditions. This test is essential for pediatric patients presenting with craniofacial abnormalities, as it provides crucial information for diagnosis and treatment planning.
What the Test Measures
This test utilizes Next Generation Sequencing (NGS) technology to detect any mutations in the FGFR1 gene. By analyzing the genetic material, healthcare providers can ascertain whether a patient has inherited conditions linked to this gene, thereby allowing for appropriate medical interventions.
Who Should Consider This Test?
Parents or guardians of children exhibiting symptoms such as:
- Craniofacial abnormalities
- Developmental delays
- Other dysmorphological features
Individuals with a family history of FGFR1 gene-related conditions should also consider this test, as it can provide insights into hereditary risks.
Benefits of Taking the Test
- Early diagnosis of genetic conditions
- Informed decision-making regarding treatment options
- Identification of potential risks for family members
- Access to genetic counseling for better understanding of results
Understanding Your Results
Results from the FGFR1 Gene Trigonocephaly Type 1 NGS Genetic DNA Test typically take 3 to 4 weeks. Once received, a genetic counselor will help interpret the findings, discussing the implications for the patient and their family. Understanding these results is crucial for planning any necessary interventions.
Test Pricing
Price Type | Amount (NGN) |
---|---|
Discount Price | 400000 NGN |
Regular Price | 560000 NGN |
Book the Test
To book the FGFR1 Gene Trigonocephaly Type 1 NGS Genetic DNA Test, please contact us at +2348077798758 via call or WhatsApp. Ensure you have a clinical history ready and consider scheduling a genetic counseling session to discuss your family’s medical background.